vs

Side-by-side financial comparison of NPK International Inc. (NPKI) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $75.2M, roughly 1.1× NPK International Inc.). On growth, NPK International Inc. posted the faster year-over-year revenue change (30.7% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 23.9%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

NPKI vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.1× larger
PRCT
$83.1M
$75.2M
NPKI
Growing faster (revenue YoY)
NPKI
NPKI
+10.5% gap
NPKI
30.7%
20.2%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
23.9%
NPKI

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NPKI
NPKI
PRCT
PRCT
Revenue
$75.2M
$83.1M
Net Profit
$-31.6M
Gross Margin
37.7%
64.9%
Operating Margin
16.7%
-4.1%
Net Margin
-38.1%
Revenue YoY
30.7%
20.2%
Net Profit YoY
-27.9%
EPS (diluted)
$0.17
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPKI
NPKI
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$75.2M
$76.4M
Q3 25
$68.8M
$83.3M
Q2 25
$68.2M
$79.2M
Q1 25
$64.8M
$69.2M
Q4 24
$57.5M
$68.2M
Q3 24
$44.2M
$58.4M
Q2 24
$66.8M
$53.4M
Net Profit
NPKI
NPKI
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-29.8M
Q3 25
$5.7M
$-21.4M
Q2 25
$8.7M
$-19.6M
Q1 25
$10.0M
$-24.7M
Q4 24
$-18.9M
Q3 24
$-174.3M
$-21.0M
Q2 24
$8.0M
$-25.6M
Gross Margin
NPKI
NPKI
PRCT
PRCT
Q1 26
64.9%
Q4 25
37.7%
60.6%
Q3 25
31.9%
64.8%
Q2 25
36.9%
65.4%
Q1 25
39.0%
63.9%
Q4 24
39.2%
64.0%
Q3 24
27.5%
63.2%
Q2 24
37.2%
59.0%
Operating Margin
NPKI
NPKI
PRCT
PRCT
Q1 26
-4.1%
Q4 25
16.7%
-40.6%
Q3 25
13.2%
-27.8%
Q2 25
17.0%
-28.0%
Q1 25
20.9%
-39.7%
Q4 24
20.2%
-28.9%
Q3 24
2.8%
-38.4%
Q2 24
18.7%
-50.3%
Net Margin
NPKI
NPKI
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-39.1%
Q3 25
8.2%
-25.7%
Q2 25
12.7%
-24.7%
Q1 25
15.4%
-35.8%
Q4 24
-27.6%
Q3 24
-394.3%
-35.9%
Q2 24
12.0%
-48.0%
EPS (diluted)
NPKI
NPKI
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$0.17
$-0.54
Q3 25
$0.07
$-0.38
Q2 25
$0.10
$-0.35
Q1 25
$0.11
$-0.45
Q4 24
$0.10
$-0.34
Q3 24
$-1.99
$-0.40
Q2 24
$0.09
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPKI
NPKI
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$5.1M
$245.6M
Total DebtLower is stronger
$16.9M
$51.7M
Stockholders' EquityBook value
$351.2M
$347.7M
Total Assets
$441.8M
$487.1M
Debt / EquityLower = less leverage
0.05×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPKI
NPKI
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$5.1M
$286.5M
Q3 25
$35.6M
$294.3M
Q2 25
$26.0M
$302.7M
Q1 25
$20.8M
$316.2M
Q4 24
$17.8M
$333.7M
Q3 24
$42.9M
$196.8M
Q2 24
$35.1M
$214.1M
Total Debt
NPKI
NPKI
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$16.9M
$51.6M
Q3 25
$9.5M
$51.6M
Q2 25
$9.3M
$51.5M
Q1 25
$8.1M
$51.5M
Q4 24
$7.7M
$51.5M
Q3 24
$14.0M
$51.4M
Q2 24
$58.0M
$51.4M
Stockholders' Equity
NPKI
NPKI
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$351.2M
$365.9M
Q3 25
$333.9M
$380.3M
Q2 25
$328.8M
$385.8M
Q1 25
$326.9M
$389.2M
Q4 24
$326.5M
$402.2M
Q3 24
$316.5M
$241.2M
Q2 24
$426.6M
$251.8M
Total Assets
NPKI
NPKI
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$441.8M
$508.1M
Q3 25
$404.5M
$511.5M
Q2 25
$393.7M
$513.1M
Q1 25
$390.0M
$519.4M
Q4 24
$393.7M
$534.0M
Q3 24
$389.6M
$374.1M
Q2 24
$624.8M
$374.4M
Debt / Equity
NPKI
NPKI
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.05×
0.14×
Q3 25
0.03×
0.14×
Q2 25
0.03×
0.13×
Q1 25
0.02×
0.13×
Q4 24
0.02×
0.13×
Q3 24
0.04×
0.21×
Q2 24
0.14×
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPKI
NPKI
PRCT
PRCT
Operating Cash FlowLast quarter
$18.0M
Free Cash FlowOCF − Capex
$5.8M
FCF MarginFCF / Revenue
7.6%
Capex IntensityCapex / Revenue
16.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$26.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPKI
NPKI
PRCT
PRCT
Q1 26
Q4 25
$18.0M
$-10.3M
Q3 25
$24.7M
$-6.6M
Q2 25
$21.4M
$-15.0M
Q1 25
$8.8M
$-17.0M
Q4 24
$-4.1M
$-32.4M
Q3 24
$2.8M
$-18.8M
Q2 24
$27.6M
$-15.7M
Free Cash Flow
NPKI
NPKI
PRCT
PRCT
Q1 26
Q4 25
$5.8M
$-12.2M
Q3 25
$12.0M
$-9.5M
Q2 25
$9.7M
$-17.8M
Q1 25
$-1.2M
$-18.8M
Q4 24
$-17.7M
$-33.6M
Q3 24
$-6.7M
$-19.0M
Q2 24
$21.0M
$-16.8M
FCF Margin
NPKI
NPKI
PRCT
PRCT
Q1 26
Q4 25
7.6%
-15.9%
Q3 25
17.4%
-11.4%
Q2 25
14.3%
-22.5%
Q1 25
-1.8%
-27.2%
Q4 24
-30.8%
-49.2%
Q3 24
-15.2%
-32.6%
Q2 24
31.4%
-31.4%
Capex Intensity
NPKI
NPKI
PRCT
PRCT
Q1 26
Q4 25
16.3%
2.4%
Q3 25
18.5%
3.4%
Q2 25
17.1%
3.5%
Q1 25
15.5%
2.7%
Q4 24
23.6%
1.7%
Q3 24
21.4%
0.4%
Q2 24
9.9%
2.0%
Cash Conversion
NPKI
NPKI
PRCT
PRCT
Q1 26
Q4 25
Q3 25
4.37×
Q2 25
2.47×
Q1 25
0.88×
Q4 24
Q3 24
Q2 24
3.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NPKI
NPKI

Rental Revenue$34.8M46%
Products$25.5M34%
Services$14.9M20%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons